Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2013 March;38(1) > Minerva Endocrinologica 2013 March;38(1):47-58

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

  CLINICAL ENDOCRINOLOGY


Minerva Endocrinologica 2013 March;38(1):47-58

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Bariatric surgery for type 2 diabetes: to whom and when?

Samaras K.

Department of Endocrinology St Vincent’s Hospital, Diabetes and Obesity Group, Garvan Institute of Medical Research, Sydney, Australia


PDF  


Achieving clinical and biochemical targets in type 2 diabetes mellitus (diabetes) is fundamental to preventing diabetic microvascular and macrovascular complications. These clinical imperatives are made more challenging in the setting of obesity. This review examines the evidence for bariatric surgery as a means of optimizing diabetes care, addressing diabetes resolution, glucose and lipid metabolism and cardiac effects. Mechanistic evidence of diabetes amelioration is summarized. The question of when bariatric surgery should be offered in the course of obesity-associated diabetes is discussed. Current guidelines and specialist society recommendations for bariatric surgery in diabetes are summarized.

top of page

Publication History

Cite this article as

Corresponding author e-mail

k.samaras@garvan.org.au